Skye Bioscience, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Skye Bioscience, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2012 to Q3 2024.
  • Skye Bioscience, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.07M.
  • Skye Bioscience, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $2.38M.
  • Skye Bioscience, Inc. annual Nonoperating Income (Expense) for 2023 was -$2.91M, a 150% decline from 2022.
  • Skye Bioscience, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.16M, a 73% decline from 2021.
  • Skye Bioscience, Inc. annual Nonoperating Income (Expense) for 2021 was -$672K, a 149% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.38M $1.07M +$1.31M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.07M $511K +$776K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $296K $1.13M +$3.2M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$2.91M -$334K +$273K +45% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$3.18M -$240K -$35.1K -17.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$3.14M -$265K -$69.1K -35.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$3.08M -$2.07M -$1.91M -1231% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$1.16M -$607K -$556K -1098% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$607K -$205K -$199K -3491% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$408K -$196K -$3.02K -1.57% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$404K -$155K +$268K +63.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$672K -$50.7K +$133K +72.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$805K -$5.71K -$247K -102% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$558K -$193K +$5.23K +2.64% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$563K -$423K -$293K -224% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$270K -$183K -$6.88M -103% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $6.61M $242K +$3.67M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.94M -$198K -$17.9M -101% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $20.8M -$130K +$13.1M +99% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $7.69M $6.7M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$3.43M -$2.38M -226% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $17.7M +$19.3M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$13.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 -$1.05M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1.58M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q2 2014 $8.24K $3.71K +$5.96K May 1, 2014 Jul 31, 2014 10-Q 2014-09-15
Q1 2014 $2.28K -$83* +$404 Jan 31, 2014 Apr 30, 2014 10-Q 2014-06-05
Q4 2013 $1.87K $4.85K -$1.59K -24.6% Nov 1, 2013 Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $3.46K -$237 Aug 1, 2013 Oct 31, 2013 10-K 2014-01-27
Q2 2013 -$2.25K -$2.4K May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 -$487 -$656 Jan 31, 2013 Apr 30, 2013 10-Q 2014-06-05
Q4 2012 $6.44K Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q2 2012 $148* May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 $169* Jan 31, 2012 Apr 30, 2012 10-Q 2013-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.